4Snell N J. Ribavirin-current status of a broad spectrum antiviral agent. Expert Opin Pharmacother, 2001, 2(8): 1317-1324.
5L.Meyer.Jones.兽医药理学与治疗学.上海:上海科学技术文献出版社,1985.
6何平平.卫生统计学实习[D].北京:北京大学,2007.
7Connor E, Morrison S, Lane J, Oleske J, Sonke R L, Connor J. Safety, Tolerance and pharmacokinetics of systemic ribavirin in children with human Immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy, 1993, 37(3): 532-539.
8Preston S L, Drusano G L, Glue P, Nash J, Gupta S K, McNamara P. Pharmaeokineties and absolute bioavilability of ribavirin in healthy volunteers as determined by stable-isotope methodology. Antimicrobial Agents and Chemotherapy, 1999, 43( 10): 2451-2456.
9Gilbert B E, WydeP R. Pharmacokinetics of ribavirin aerosol in mice. Antimicrobial Agents and Chemotherapy, 1988, 32(1): 117-121.
10Lin C C, Ych L T, Luu T, Lourenco D, Lau J Y N. Pharmacokinetics and metabolism of [^14C]ribavirin in rats and cynomolgus monkeys. Antimicrobial Agents and Chemotherapy, 2003, 47(4): 1395-1398.
